Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 801 - 850 out of 3,730

Document Document Title
WO/2007/019397A2
Disclosed are compounds, compositions and methods for treatingFlaviviridae family virus infections. Formulae (I), (II) and (III) wherein: B and D are independently N or C-L1-R1; with the proviso that at least one of B or D is N or CH; A ...  
WO/2007/015533A1
Disclosed is a novel amidine compound which can serve as an active ingredient of a highly safe herbicide which shows a reliable effect at a low dose. Also disclosed is a herbicide comprising the compound as an active ingredient. An amidi...  
WO/2007/015414A1
An Sym-triindole derivative which has excellent film-forming properties and is bipolar. Even when used to form a single-layer organic EL element, the derivative luminesces. It is hence widely applicable to the field of organic EL materia...  
WO/2007/013694A1
A compound represented by the general formula (I): (I) wherein each symbol is as defined in the description. The compound is excellent in the effect of decreasing the blood glucose level and the blood lipid level, and therefore is useful...  
WO/2007/013830A1
New compounds of formula I are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.  
WO/2007/011003A1
A liquid crystal compound is provided and includes a region in which an aromatic heterocyclic ring and an aromatic hydrocarbon ring linked together through a single bond, the liquid crystal compound expressing a nematic liquid crystal ph...  
WO/2007/010653A1
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...  
WO/2007/003960A1
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.  
WO/2007/002557A1
The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and meth...  
WO/2007/002764A2
Disclosed are compounds of the formula (1). and the pharmaceutically acceptable salts thereof. X is N or N+O-, and Y is N or N+O-, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine-mediated disea...  
WO/2006/134317A1
Compounds of Formula (I): wherein R1- R2, W and Y are as described m the specification, and their salts and pro-drugs, are inhibitors of DGAT and are thereby useful in the treatment of, for example, obesity. Processes for preparing compo...  
WO/2006/133216A2
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.  
WO/2006/131336A1
Disclosed are polycyclic compounds of formula I which are useful as sphingosine-1 -phosphate (S 1 P) receptor ligands, particularly as immunosuppressants.  
WO/2006/128657A1
The use of a metathesis catalyst in the preparation of a functionalized sphingolipid.  
WO/2006/125637A1
The present invention relates to a method of combating animal pests which comprises contacting the animal pest, their habit, breeding ground, food supply, plant, seed, soil, area, material or environment in which the animal pests are gro...  
WO/2006/122949A1
Malononitrile compounds of formula (I) wherein R1 is H, (halo)alkyl, (halo)alkenyl, or (halo)alkynyl; R2 is H1 CN, (halo)alkyl, (halo)alkenyl, (halo)alkynyl, (halo)cycloalkyl, or (halo)alkoxy; R3 and R4 are H, (halo)alkyl, (halo)alkenyl,...  
WO/2006/123486A1
A method for producing a 1,2,4-oxadiazol derivative represented by the formula (1): (1) [wherein, R1 represents a methyl group or a phenyl group, and R2 represents an optionally substituted linear or branched alkyl group], which comprise...  
WO/2006/122150A1
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.  
WO/2006/120133A2
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.  
WO/2006/109817A1
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein R1 represents a branched alkyl group having 3 to 9 carbon atoms or the like; R2 represents a 6-membered heteroaryl group having 1 or 2 n...  
WO/2006/105127A2
Compounds, pharmaceutical compositions, kits and methods are provided for use with hydroxysteroid dehydrogenases that comprise a compound selected from the group consisting of: formula (I), wherein the variables are as defined herein.  
WO/2006/102645A1
The invention is directed to novel vanilloid receptor type 1 (VR1) ligands. More specifically, the invention relates to novel biaryl-derived amides that are potent antagonists or agonists of VR1. Pharmaceutical and veterinary composition...  
WO/2006/100502A1
There is provided a compound having Formula (I ) R1-Z-R2 wherein R1 is a group selected from optionally substituted fused polycyclic groups, substituted alkyl groups, branched alkyl groups, and optionally substituted cycioalkyl groups Z ...  
WO/2006/098489A1
A compound useful for fabrication of retardation plates, which is represented by the formula (DI): wherein Y11 to Y13 represent methine or nitrogen; R11 to R13 represent a group of the formula (DI-A) below or others: wherein A11 to A16 r...  
WO/2006/085108A1
Therapeutically active anthranilic acid derivatives of Formula (I) wherein R1, R2, W, Y and Z are as defined in the specification, processes for the preparation of said derivatives, pharmaceutical formulations containing the active compo...  
WO/2006/085112A1
Therapeutically active anthranilic acid derivatives of Formula (I) wherein R1, R2 and W, are as defined in the specification, processes for the preparation of said derivatives, pharmaceutical formulations containing the active compounds ...  
WO/2006/083271A2
The invention provides certain acylthiourea derivatives and pharmaceutically acceptable salts thereof. These compounds possess potent antiviral activity. The invention particularly provides compounds that are potent and/or selective inhi...  
WO/2006/078754A1
The present invention relates generally to the synthesis of novel quinolinium salts and derivative compounds. Such salts and compounds are useful for inhibiting the growth of cancer cells.  
WO/2006/078995A1
The invention describes compositions and kits comprising at least one cardiovascular compound comprising at least one heterocyclic nitric oxide donor group, and, optionally, at least one nitric oxide enhancing compound and/or at least on...  
WO/2006/078577A1
The present invention is directed to tertiary carbinamine compounds having substituted heterocycles, which are inhibitors of the beta-secretase enzyme, and are useful in the treatment of diseases in which the beta-secretase enzyme is inv...  
WO/2006/074796A1
Compounds of the formula (1) in which R1, R2, X, Y and Z are as defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the ...  
WO/2006/069808A2
The present invention relates to nitro-substituted phenyl-piperazine compounds of general formula I, a process for their preparation, medicaments comprising said nitro-substituted phenyl-piperazine compounds as well as the use of said ni...  
WO/2006/070878A1
It is intended to provide a compound which has an anticoagulant effect based on the inhibition of the activated blood coagulation factor VII and, therefore, is useful as a blood coagulation inhibitor or a preventive/remedy for diseases c...  
WO/2006/069685A1
The invention relates to compounds of formula (I), where A1, A2, R1, R2, R3, R4, R5 and Y have the meanings given in the description, methods and intermediates for production thereof and use thereof for the prevention of pests.  
WO/2006/071184A1
Compounds of Formula I: wherein R1, R2, R3, R4, R5 Ar1 and X are as described in the specification, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in the...  
WO/2006/069656A1
The invention relates to compounds of the formula (I) in which R1, R2, X, A, B, D and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as ...  
WO/2006/067472A1
A compound of the formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R2, R3, R4 and R5 are independently selected from the group consisting of H, C1-7 alkoxy, amino, halo or hydroxy; n is...  
WO/2006/064757A1
A compound represented by the general formula (I), a salt thereof, an N-oxide form thereof, a solvate thereof, or a prodrug of any of these; and a drug containing any of these. (I) (In the formula, all the symbols are as defined in the d...  
WO/2006/066126A2
Ligands, compositions, and metal-ligand complexes that incorporate phenol-heterocyclic compounds are disclosed that are useful in the catalysis of transformations such as the polymerization of monomers into polymers. The catalysts have h...  
WO/2006/065277A2
Disclosed are compounds of the formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, and pharmaceutical compositions comprising the compounds of formula (I). Also disclosed is the method of inhi...  
WO/2006/064189A1
Compounds of formula (I), and salts and pro-drugs thereof: Formula (I) wherein for example R1 is optionally substituted aryl or heteroaryl; Y is a linking group selected from, for example, a direct bond, and a (substituted) alkyl chain; ...  
WO/2006/062224A1
An SGLT inhibitor comprising a compound of the formula: (&Verbar ) wherein the ring A is an optionally substituted ring; R1 is an optionally substituted hydrocarbon group, etc.; each of R2 and R3 independently is a hydrogen atom, an opti...  
WO/2006/059245A2
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing CNS and amyloid associated disease. Also described are methods, compounds, pharmaceutical compositions and kits for detecting, diagnosing, ...  
WO/2006/059149A1
Compounds of formula (I) are potent and selective 5-HT2A antagonists, useful in treatment of a variety of adverse conditions of the CNS.  
WO/2006/051704A1
An imine compound represented by the formula (X) (wherein A represents a heterocyclic group; R1, R2, and R3 each represents hydrogen, halogeno, C1-10 alkyl optionally substituted by haloaryl, C3-10 cycloalkyl, C1-6 haloalkyl, C1-10 alkox...  
WO/2006/050435A1
NLO chromophores of the form of Formula (I) and the acceptable salts, solvates and hydrates thereof, wherein Z, X1-4, &pgr 1-2, D and A have the definitions provided herein.  
WO/2006/044359A2
Novel heterocyclic aromatic compounds are provided that are useful in stimulating endogenous production or release of growth hormone, said compounds having the general structure of formula I wherein R1, Rla, R6, Xa, Xb and Y are as descr...  
WO/2006/044133A1
The present invention related to certain active tetracyclic ketone inhibitors of tryptase, pharmaceutical composition comprising these compounds and methods of treating asthma, allergic rhinitis, and/or Chronic Obstructive Pulmonary Dise...  
WO/2006/043539A1
Disclosed are a light-emitting compound and a light-emitting polymer compound which emit blue light or the like and contain pyrene. Also disclosed is a light-emitting device. Specifically disclosed are a light-emitting compound and a lig...  
WO/2006/044682A1
The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particu...  

Matches 801 - 850 out of 3,730